NCT05759455

Brief Summary

In the present study, we aim to evaluate the serum level of 25 hydrxy vitamin D in autistic children .

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2023

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 26, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 8, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

March 8, 2023

Status Verified

February 1, 2023

Enrollment Period

Same day

First QC Date

February 26, 2023

Last Update Submit

February 26, 2023

Conditions

Assessment of Vitamin D Level in Children With Autism in Assiut University Children Hospital

Outcome Measures

Primary Outcomes (1)

  • Assessment of Vitamin D level in Children with Autism in assiut university children hospital

    In the present study, we aim to evaluate the serum level of 25 hydrxy vitamin D in autistic children .

    2 years

Interventions

vitamin dDIETARY_SUPPLEMENT

Assessment of Vitamin D level in Children with Autism in assiut university children hospital

Eligibility Criteria

Age10 Months - 18 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

1. full history. 2. full clinical examination. 3. diagnosis of patients with ASD based on medical experience,clinical examination and two criteria of DSM-IV . 4. evaluation of serum 25 hydroxy vitamin D level ; 5 ml of venous blood sample is taken for the test.

You may qualify if:

  • Patient who full filled the diagnostic criteria of autism spectrum disorder according to DSM-IV.

You may not qualify if:

  • )Children using vitamin D supplement. 2)patients with associated congenital malformation. 3)patients with chromosomal abnormalities. 4)patients with chronic physical illness. 5)patients with epilepsy. 6)patients with hepatic or renal disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Interventions

Vitamin D

Intervention Hierarchy (Ancestors)

SecosteroidsSteroidsFused-Ring CompoundsPolycyclic Compounds

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assiutU

Study Record Dates

First Submitted

February 26, 2023

First Posted

March 8, 2023

Study Start

September 1, 2023

Primary Completion

September 1, 2023

Study Completion

December 1, 2023

Last Updated

March 8, 2023

Record last verified: 2023-02